medigraphic.com
SPANISH

Revista Cubana de Obstetricia y Ginecología

ISSN 1561-3062 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2021; 47 (4)

Influence of embolizing material used in the treatment of uterine fibroids

de la Cruz OA, Vázquez LF, Suárez OJ, Roque GR, Olazábal GE
Full text How to cite this article

Language: Spanish
References: 24
Page:
PDF size: 602.93 Kb.


Key words:

embolizing material, embolization of uterine arteries, uterine fibroma.

ABSTRACT

Introduction: The embolization of uterine arteries constitutes a therapeutic alternative for the treatment of uterine fibroids. There are different types of embolizing materials, but not all of them have the same effect on the evolution of patients.
Objective: To evaluate how the material used in the embolization of uterine arteries influences in the results before and after treatment.
Methods: An observational, descriptive study was conducted from a sample of 19 patients with uterine fibroma treated at the National Center for Minimum Invasive Surgery of Havana, from January to December 2019. The main variables to evaluate the effect of treatment were menstrual bleeding, major fibroma length and uterine volume.
Results: The embolizing materials used decrease vaginal bleeding, fibroma size and uterine volume, at the beginning, at three months and six months of evaluating the treatment, and the behavior was similar for the three materials.
Conclusions: The different embolizing materials used showed a capacity to reduce vaginal bleeding in the post-plant period, as well as the size of fibroma and uterine volume.


REFERENCES

  1. Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet (London, England). 1995;346(8976):671-2.

  2. Wang YC, Hu J, Sheth RA, Oklu R. Emerging embolic agents in endovascular embolization: an overview. Prog. Biomed. Eng. 2020;2:01-2003. DOI: https://doi.org/10.1088/2516-1091/ab6c7d

  3. Redondo M. Agentes embolizantes. Indicaciones clásicas y novedades. Intervencionismo. 2018 [acceso 19/10/2020];18(1):20-38. Disponible en: http://revistaintervencionismo.com/wp-content/uploads/2018/01/2018_01_intervencionismo_revision.pdf

  4. Sheth RA, Sabir S, Krishnamurthy S, Avery RK, Zhang YS, Khademhosseini A, et al. Endovascular Embolization by Transcatheter Delivery of Particles: Past, Present, and Future. J Funct Biomater. 2017 [acceso 14/11/2019];8(2):12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491993/

  5. Toor SS, Jaberi A, Macdonald DB, McInnes MD, Schweitzer ME, Rasuli P. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol. 2012 [acceso 20/12/2018];199(5):1153-63. Disponible en: https://www.ajronline.org/doi/10.2214/AJR.11.8362

  6. Korashi H, Soliman A, Shimy A. Assessing Safety and Efficacy of Uterine Artery Embolization in Symptomatic Uterine Fibroids. Med. J. Cairo Univ. 2019 [acceso 02/11/2020];87(9):3089-95. Disponible en: https://www.medicaljournalofcairouniversity.net

  7. Rodríguez Linares JE, Torres Cuevas BL, Maldonado Cantillo G. La embolización selectiva de arterias uterinas como alternativa en el tratamiento del fibroma uterino. Rev Cubana Obstet Ginecol. 2015 [acceso 13/08/2018];41(2):140-9. Disponible en: http://scieloprueba.sld.cu/pdf/gin/v41n2/gin06215.pdf

  8. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016 [acceso 14/02/2019];22(6):665-86. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC5853598/

  9. Szkodziak P, Szkodziak F, Trzeciak K, Czuczwar P. Minimally invasive procedures in the management of uterine fibroids. Prz Menopauzalny. 2017 [acceso 14/02/2019];16(4):122-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC5824681/

  10. Chung YJ, Kang SY, Chun HJ, Rha SE, Cho HH, Kim JH, et al. Development of a model for the prediction of treatment response of uterine leiomyomas after uterine artery embolization. Int J Med Sci. 2018 [acceso 16/02/2020];15(14):1771-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC6299417/

  11. Lucino S, Ñañez ML, Castellari M, Oulton C. Embolización arterial de miomas uterinos: resultados morfológicos y funcionales a corto y mediano plazo. Rev Argent Radiol. 2010 [acceso 15/10/2018];74(2):159-70. Disponible en: https://www.redalyc.org/pdf/3825/382538482006.pdf

  12. de Bruijn AM, Adriaansens S-OJH, Smink M, Venmans A, Hehenkamp WJK, Smeets AJ, et al. Uterine artery embolization in women with symptomatic cervical leiomyomata: efficacy and safety. Cardiovasc Intervent Radiol. 2019 [acceso 13/02/2019];42(3):371-80. Disponible en: https://doi.org/10.1007/s00270-018-2081-2

  13. Zlotnik E, Lorenzo Messina Md, Nasser F, Affonso BB, Baroni RH, Wolosker N, et al. Predictive factors for pelvic magnetic resonance in response to arterial embolization of a uterine leiomyoma. Clinics (Sao Paulo, Brazil). 2014 [acceso 15/02/2019];69(3):185-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC3935123/

  14. Scheurig C, Gauruder-Burmester A, Kluner C, Kurzeja R, Lembcke A, Zimmermann E, et al. Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod. 2006 Dec [acceso 06/11/2020];21(12):3270-7. Disponible en: https://academic.oup.com/humrep/article-pdf/21/12/3270/9682322/del275.pdf

  15. Navarro M, Mallola MC, Carmona MA, García-Entrena A, Parrillaa F. Embolización arterial uterina. Resultados a corto plazo. Clin Inv Gin Obst. 2004 [acceso 06/11/2020];31(10):348-52. Disponible en: http://www.sciencedirect.com/science/article/pii/S0210573X04773657

  16. Córdoba-Esquivel JA, Guerrero-Avendaño GM, Enríquez-García R. Influencia de los materiales embolizantes en el tamaño de los miomas posterior a la embolización de arterias uterinas. An Radiol Méx. 2018 [acceso 13/08/2018];17(1):3-9. Disponible en: http://www.medigraphic.com/pdfs/anaradmex/arm-2018/arm181b.pdf

  17. Rasuli P, Hammond I, Al-Mutairi B, French GJ, Aquino J, Hadziomerovic A, et al. Spherical versus conventional polyvinyl alcohol particles for uterine artery embolization. J Vasc Interv Radiol. 2008 Jan [acceso 06/11/2020];19(1):42-6. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S1051044307011256.pdf?locale=es_ES&searchIndex=

  18. Das R, Champaneria R, Daniels JP, Belli AM. Comparison of Embolic Agents Used in Uterine Artery Embolisation: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol. 2014 [acceso 04/11/2020];37(5):1179-90. Disponible en: https://link.springer.com/content/pdf/10.1007/s00270-013-0790-0.pdf

  19. Gao Y, Jiang F, Wang X. Tri-acryl gelatin microsphere is better than polyvinyl alcohol in the treatment of uterine myomas with uterine artery embolization. Int J Clin Exp Med. 2015 [acceso 06/11/2020];8(6):8749-57. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538040/pdf/ijcem0008-8749.pdf

  20. Guirola JA, Sánchez-Ballestin M, Sierre S, Lahuerta C, Mayoral V, De Gregorio MA. A Randomized Trial of Endovascular Embolization Treatment in Pelvic Congestion Syndrome: Fibered Platinum Coils versus Vascular Plugs with 1-Year Clinical Outcomes. J Vasc Interv Radiol. 2018 [acceso 06/11/2020];29(1):45-53. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S1051044317308655.pdf?locale=es_ES&searchIndex

  21. Loffroy R. Onyx vs Squid vs. Phil. GEST 2017 [acceso 06/11/2020]. Disponible en: https://s3.eu-central-1.amazonaws.com/metadcr/170531_6110_CIRSE_GEST_2017_Florenz/download/download_47198_un.pdf

  22. Shimohira M, Kawai T, Hashizume T, Muto M, Kitase M, Shibamoto Y. Usefulness of Hydrogel-Coated Coils in Embolization of Pulmonary Arteriovenous Malformations. Cardiovasc Intervent Radiol. 2018 [acceso 06/11/2020];41(6):848-55. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937894/pdf/270_2018_Article_1876.pdf

  23. Haochen W, Jian W, Li S, Tianshi L, Xiaoqiang T, Yinghua Z. Superselective renal artery embolization for bleeding complications after percutaneous renal biopsy: a single-center experience. The Journal of international medical research. 2019 Apr [acceso 06/11/2020];47(4):1649-59. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/0300060519828528

  24. Venturini M, Marra P, Augello L, Colarieti A, Guazzarotti G, Palumbo D, et al. Elective Embolization of Splenic Artery Aneurysms with an Ethylene Vinyl Alcohol Copolymer Agent (Squid) and Detachable Coils. J Vasc Interv Radiol. 2020 Jul [acceso 06/11/2020];31(7):1110-7. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S1051044319318615.pdf?locale=es_ES&searchIndex=




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Cubana de Obstetricia y Ginecología. 2021;47